Nursing care
Enteral Medication Administration: the nurse's role, start to finish
Written and reviewed by Dana Whitfield, RN, MSN · 5 min read · Updated September 2026
Short answer
Enteral medication administration delivers drugs through a nasogastric, gastrostomy, or jejunostomy tube directly into the GI tract, bypassing oral intake. The nurse must confirm tube placement, never crush enteric-coated or extended-release tablets since that releases a full day's dose at once, and flush before and after each drug to prevent occlusion and drug interactions within the tube.
What the procedure achieves
Enteral medication administration allows patients who cannot swallow safely, who are unconscious, or who have a feeding tube for nutritional support to still receive their prescribed medications through the same access point. This covers nasogastric, orogastric, gastrostomy, and jejunostomy routes, each requiring the drug to reach the stomach or small intestine rather than the mouth and oesophagus.
The purpose is continuity of treatment without forcing an unsafe oral route or a switch to injectable alternatives that may not exist for every drug. It carries specific risks the oral route does not: tube occlusion, aspiration if the tube has migrated, and altered drug bioavailability when a formulation designed for gradual release is crushed and delivered as a bolus.
Pre-procedure nursing responsibilities
Confirm tube placement before every medication pass, not just at insertion. Check the documented external tube length against the current measurement, aspirate for gastric contents where appropriate, and follow facility policy on pH testing or radiographic confirmation for newly placed tubes. A tube that has migrated into the oesophagus or lungs turns medication administration into an aspiration risk.
Review each drug on the medication administration record against its formulation. Enteric-coated and extended-release tablets must never be crushed — the coating exists to protect the drug from stomach acid or to release it slowly over hours, and crushing destroys that mechanism, delivering the full day's dose in a single bolus with a real risk of toxicity. Where a drug cannot be crushed or opened, contact the pharmacist or prescriber for a liquid formulation or an alternative agent rather than crushing it anyway.
Equipment and positioning
Gather an appropriate syringe, usually an oral or enteral-specific syringe that will not connect to intravenous lines, along with water for flushing, a pill crusher for drugs that are safe to crush, and a mortar and pestle or crushing pouch kept separate from other patients' equipment. Crush each tablet separately and dissolve it fully in water before drawing it up, since undissolved particles are a leading cause of tube occlusion.
Position the patient sitting upright or with the head of the bed elevated to at least thirty degrees, and maintain that position for at least thirty minutes after administration. This reduces the risk of reflux and aspiration, particularly important for nasogastric tubes feeding into the stomach. Flush the tube with the volume specified by policy, typically fifteen to thirty millilitres, before the first drug and between each subsequent drug, then flush again after the last one.
Complications and early signs
Tube occlusion is the most common complication and usually results from inadequate flushing, undissolved medication, or mixing incompatible drugs in the same syringe. Resistance when flushing, an inability to aspirate, or medication visibly backing up the tube are early signs that need addressing before the next dose rather than forcing fluid through under pressure.
Aspiration is the more serious risk, signalled by coughing, choking, a sudden drop in oxygen saturation, or crackles on auscultation during or after administration. This is more likely if tube placement was not reconfirmed or if the patient was not positioned upright. Diarrhoea can also follow enteral medication administration, often from the sorbitol or hyperosmolar vehicles used in liquid formulations rather than the active drug itself, and this is worth distinguishing from an infectious cause before treatment is changed.
Post-procedure care
Document the drugs given, the flush volumes used before and after, tube placement confirmation, and the patient's tolerance, including any coughing, resistance during administration, or gastrointestinal symptoms. Keep the patient upright for the recommended period and monitor for delayed signs of aspiration, which can present up to an hour after the dose.
If any drug required a formulation change, such as a liquid substitute for a tablet that could not be crushed, note that clearly so subsequent doses are prepared consistently and the change is visible to the next shift. Reassess tube patency at the end of the medication round, and flag any drug that caused resistance during flushing for pharmacy review before the next scheduled dose.
What to teach before discharge
For patients or caregivers managing a gastrostomy or jejunostomy tube at home, teach that no tablet should be crushed without first checking with a pharmacist, since enteric-coated and extended-release formulations look identical to ordinary tablets but behave very differently once crushed. A missed identification here can mean a full day's dose of a drug like a slow-release opioid or a cardiac medication entering the system all at once.
Teach the flush routine in concrete terms — water before, between, and after every medication, using the volume the care team has specified — and explain that this is not optional even when only one drug is given. Show them how to recognise resistance during a flush and what to do if it occurs, and make clear that persistent coughing, choking, or breathlessness during or after a dose needs urgent review rather than waiting for the next visit.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our pharmacology practice questions are the closest set to what this page covers.
One question from the pharmacology set
A client with heart failure is started on furosemide 40 mg PO daily. Which findings should the nurse report to the provider before administering the next dose? Select all that apply.
Rationale
Furosemide is a loop diuretic, so the two things you are watching are potassium and kidney function. A potassium of 2.9 mEq/L is below the 3.5–5.0 reference range and puts the client at risk for dysrhythmia — hold and report. Muscle cramps with palpitations are the clinical face of that same hypokalemia, so they are reported together, not separately. A creatinine that doubles signals the diuresis has outrun renal perfusion. A blood pressure of 132/78 and a 1 kg loss are the expected response to the drug working, not reasons to hold it.
Answer: A, D, E
Common questions
Can you crush an enteric-coated tablet for a feeding tube?
No. Enteric-coated and extended-release tablets must never be crushed, because doing so destroys the mechanism that controls how and where the drug is released, delivering the entire day's dose at once. Ask the pharmacist for a liquid or alternative formulation instead.
How much water should you use to flush an enteral tube?
Facility policy varies, but a common range is fifteen to thirty millilitres before the first drug, between each drug given, and again after the last one. The goal is to clear the tube fully and prevent drugs mixing or precipitating inside it.
What are the early signs of enteral tube occlusion?
Resistance when flushing, an inability to aspirate gastric contents, or medication visibly backing up the tube are the earliest signs. These should be addressed immediately rather than forcing fluid through under pressure, which can rupture the tube.
Why does the patient need to sit upright for enteral medications?
Elevating the head of the bed to at least thirty degrees during and for thirty minutes after administration reduces the risk of reflux and aspiration, particularly with nasogastric tubes feeding directly into the stomach.
Why do some patients get diarrhoea after enteral medications?
Liquid formulations often contain sorbitol or other hyperosmolar vehicles that draw water into the bowel, which can cause diarrhoea independent of the active drug. This should be considered before assuming an infectious cause.
More on pharmacology
Guides on this